Skip to Content

Patient-Ordered Testing May Up CRC Screening Adherence

THURSDAY, Feb. 4, 2021 -- The ability to self-order screening kits through electronic reminders may act as a commitment device that increases colorectal cancer (CRC) screening uptake, according to a study published online Jan. 20 in the Journal of General Internal Medicine.

Erin E. Hahn, Ph.D., M.P.H., from Kaiser Permanente Southern California in Pasadena, and colleagues compared the effectiveness of a commitment device (patient self-ordering fecal immunochemical test [FIT] kits through an electronic screening reminder) to standard CRC screening outreach (mailed kits sent to those who did not use the order button in the electronic reminder). The analysis included 176,231 participants.

The researchers found that 10 percent of participants used the self-order button. Those who used the button had higher odds of completing a kit versus participants who were automatically mailed kits (odds ratio, 3.77). Among those using the self-order button, 63 percent of those eligible completed a FIT kit in the year prior to the button becoming available versus 87 percent in the year after the button became available.

"Scalable tools leveraging existing patient portals such as this can complement existing CRC outreach strategies," the authors write.

Abstract/Full Text (subscription or payment may be required)

© 2021 HealthDay. All rights reserved.

Posted: February 2021

Read this next

Only Two in 10 Older Adults Report Being Screened for Hearing Loss

TUESDAY, March 2, 2021 -- Eight in 10 older adults say they have not been screened for hearing loss in primary care within the last two years, according to a report published...

Umbrella Review Reveals Links Between Diet, Colorectal Cancer

TUESDAY, March 2, 2021 -- Higher intakes of dietary fiber, dietary calcium, and yogurt and lower intakes of red meat and alcohol are associated with a lower risk for colorectal...

Threshold ID'd for Urine Test to Rule Out Prostate Cancer

TUESDAY, March 2, 2021 -- A urine-based test could potentially help patients safely avoid unnecessary prostate cancer biopsies, according to a study published online in the March...

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.